Bridgeway Capital Management, LLC Unity Biotechnology, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.4 - $4.27 $33,760 - $360,387	-84,400 Reduced 44.08%	107,050 $42,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.29 $25,200 - $58,050	-45,000 Reduced 19.03%	191,450 $108,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $20,160 - $52,080	28,000 Added 13.43%	236,450 $265,000
Q4 2021 Feb 14, 2022	SELL	$1.3 - $3.17 $75,400 - $183,860	-58,000 Reduced 21.77%	208,450 $304,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $686,760 - $1.06 Million	236,000 Added 775.04%	266,450 $799,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $104,139 - $193,662	30,450 New	30,450 $160,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.